Related Experiment Video
Updated: Jun 10, 2026

Evaluation of a Point-of-Care Testing Analyzer for Measuring Peripheral Blood Leukocytes
Published on: March 22, 2022
Gelofusine affects the quality control performance of QuickVue point-of-care human chorionic gonadotropin test
Douwe de Boer1, Christel Houben, Otto Bekers
1Department of Clinical Chemistry, Maastricht University Medical Centre, The Netherlands. douwe.de.boer@mumc.nl
Objective:
To characterize the influence of Gelofusine (succinylated gelatin) on the performance of point-of-care testing (POCT) for human chorionic gonadotropin (hCG) devices.
Design And Methods:
Three brands of urine and urine/serum hCG POCT devices were verified.
Results:
Succinylated gelatin affected the performance of the control band in the QuickVue hCG POCT devices. Alternative devices were not affected. The hCG test performance is not influenced.
Conclusions:
Gelofusine affects specifically the quality control performance of the QuickVue hCG POCT devices.